KRONOS BIO INC (KRON) Institutional Ownership
None of the superinvestors we track currently report KRONOS BIO INC (KRON) in their latest SEC Form 13F filings.
13F filings cover institutional equity holdings and are reported quarterly with a delay. This stock may still have insider Form 4 activity or appear in future filings.
When tracked funds report positions in KRONOS BIO INC (KRON), this page will show fund ownership trends, hedge fund exposure, portfolio concentration, historical 13F filings, and estimated holding performance.
Institutional Ownership Trend
| Portfolio quarter | Institutional holders | Total reported value | Total shares |
|---|---|---|---|
| Q1 2025 | 1 | $909,419 | 1,102,326 |
| Q4 2024 | 1 | $1,113,218 | 1,171,808 |
| Q3 2024 | 1 | $978,956 | 979,054 |
| Q2 2024 | 1 | $947,516 | 764,126 |
| Q1 2024 | 1 | $1,341 | 1,031,530 |
| Q4 2023 | 1 | $1,141 | 912,926 |
| Q3 2023 | 1 | $1,302 | 1,001,700 |
| Q2 2023 | 1 | $2,059 | 1,197,300 |
| Q1 2023 | 1 | $1,350 | 924,900 |
| Q4 2022 | 1 | $1,374 | 848,300 |
| Q3 2022 | 1 | $2,332 | 696,002 |
| Q2 2022 | 1 | $2,923 | 802,900 |
Related KRON Institutional Insights:
- KRON Institutional Ownership & Insiders Activity
- KRON Institutional Ownership & 13F Activity
- KRON Top Institutional Shareholders
- KRON Institutional Buying Activity
- KRON Institutional Selling Activity
- Institutional Portfolio Overlap & Shared Holdings
- KRON Insider Trading & SEC Form 4 Activity
- Top Institutional Investor Stock Rankings